Press release
United States Polyethylene Glycol Market 2025 | Growth Drivers, Key Players & Investment Opportunities
Polyethylene Glycol Market
Global Polyethylene Glycol (PEG) market reached US$ 4.3 billion in 2022 and is expected to reach US$ 7.1 billion by 2031, growing with a CAGR of 6.4% during the forecast period 2024-2031.
Key Development:
✅ In July 2025, the global PEG market volume reached approximately 450,000 tons in 2024, with North America accounting for nearly 27% of the share. The region continues to show steady growth driven by pharmaceutical, personal care, and industrial applications.
✅ In March 2025, Glenmark Therapeutics Inc. USA launched Polyethylene Glycol 3350 Powder for Solution (17g/capful), an OTC product and generic equivalent to MiraLAX. This launch expands Glenmark's presence in the gastrointestinal treatment market.
Mergers & Acquisitions
✅ Dec 2024: Ampersand Capital Partners acquired Nektar Therapeutics' PEG reagent manufacturing business, relaunching it as Gannet BioChem to strengthen PEGylation reagent supply in the biopharma market.
✅ May 2024: INEOS Oxide acquired LyondellBasell's Ethylene Oxide & Derivatives business for USD 700 million, securing upstream EO/EG feedstocks critical for PEG production.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/polyethylene-glycol-market?sb
Key Market Trends
✅ Rising PEGylated Biopharma Demand: Growing approval of PEG-based biologics, such as PEG-interferons and PEG-filgrastim, is boosting pharmaceutical-grade PEG consumption.
✅ Sustainable Manufacturing: Manufacturers are investing in bio-based ethylene oxide (EO) and ethylene glycol (EG) feedstocks to reduce carbon footprint in PEG production.
✅ Surge in Cosmetic Applications: Expanding personal care industries in Asia and North America are driving demand for low-molecular-weight PEGs used as humectants and solubilizers.
✅ High-Purity Grades in Focus: Global demand for high-purity PEG 4000 and PEG 6000 grades for ophthalmic and injectable formulations is steadily rising.
Key Players:
=> Dow Chemical Company, BASF SE, SABIC, Huntsman Corporation, Croda International Plc, Clariant AG, India Glycols Limited, Oxiteno, Ineos Group and LOTTE Chemical Corporation.
Future Outlook
✅ The adoption of PEG derivatives in drug delivery nanocarriers and mRNA vaccine stabilization is anticipated to create lucrative opportunities through 2033.
✅ Advancements in bio-based EO and circular chemical feedstock integration will enhance the sustainability profile of PEG production.
✅ Continued M&A activity and capacity expansions across the U.S., Europe, and Asia suggest a robust decade of strategic growth.
Research Process:
Both primary and secondary data sources have been used in the global Polyethylene Glycol (PEG) Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=polyethylene-glycol-market
Key Segments:
➥ By Type: PEG 200, PEG 300, PEG 400, PEG 600, PEG 1000, PEG 1500, PEG 3350, PEG 4000, PEG 6000, PEG 8000, PEG 10000, Others
➥ By Form: Opaque Liquid, Powder/Flakes, White Waxy Solid
➥ By Packaging Type: Drums, Plastic Bottles, Bags, Cartons, Others
➥ By Average Molecular Weight: Less than 500g/mol, 500g/mol to 1000g/mol, 1000g/mol to 4000g/mol, More than 4000g/mol
➥ By Application: Healthcare, Industrial, Cosmetics/Personal Care, Building and Construction, Plastics, Aerospace, Others
Regional Analysis for Polyethylene Glycol (PEG) Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Polyethylene Glycol (PEG) producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Polyethylene Glycol (PEG) revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/polyethylene-glycol-market?sb
FAQ
What is the current size of the Polyethylene Glycol (PEG) Market?
A: In 2023, the Polyethylene Glycol (PEG) Market was valued at US$ 4.3 billion, reflecting its strong industry presence.
Q2: How large is the Polyethylene Glycol (PEG) Market expected to be by 2031?
A: By 2031, industry forecasts suggest the Polyethylene Glycol (PEG) Market will grow to around US$ 7.1 billion , demonstrating significant expansion.
Q3: What is the growth rate of the Polyethylene Glycol (PEG) Market?
A: The market is projected to expand at a compound annual growth rate (CAGR) of 6.4% during the forecast period from 2024 to 2031.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Polyethylene Glycol Market 2025 | Growth Drivers, Key Players & Investment Opportunities here
News-ID: 4248656 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Drug Discovery Services Market to Reach USD 12.78 Billion by 2033 …
Drug Discovery Services Market Overview
The global drug discovery services market reached US$ 8.37 Billion in 2024, up from US$ 8.01 Billion in 2023, and is projected to reach US$ 12.78 Billion by 2033, expanding at a CAGR of 4.9% during 2025-2033. The market's growth is primarily driven by the increasing prevalence of chronic diseases, rising pharmaceutical R&D expenditure, and advancements in drug discovery technologies. Pharmaceutical companies are increasingly outsourcing their…
United States Biomaterials Market to Reach US$ 486.83 Million by 2033 | Rising A …
Leander, Texas and TOKYO, Japan - Dec.10.2025
Market Size
As per DataM Intelligence research report, "The Global Biomaterials Market reached US$ 177.30 million in 2024 and is expected to reach US$ 486.83 million by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033." Increasing applications in medical implants, tissue engineering, and drug delivery systems are driving market growth.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/biomaterials-market?praveen
United…
United States Blood Cancer Drugs Market to Reach USD 113.5 Billion by 2031 | Str …
Blood Cancer Drugs Market Overview
The Global Blood Cancer Drugs Market reached USD 63 billion in 2022 and is projected to grow significantly to USD 113.5 billion by 2031, exhibiting a CAGR of 7.8% during 2024-2031. The market growth is primarily driven by the rising prevalence of blood cancers, continuous advancements in cancer research, and the development of targeted therapies, immunotherapies, and personalized medicine. Increasing awareness among patients and healthcare providers,…
United States Primary Sclerosing Cholangitis Market 2031 | Growth Drivers, Key P …
Market Size and Growth
The global critical infrastructure protection market is growing at a high CAGR during the forecast period (2024-2031).
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/primary-sclerosing-cholangitis-market?sb
Key Development:
United States
✅ In December 2025, Chemomab Therapeutics published peer‐reviewed Phase 2 trial results for Nebokitug showing that 48‐week treatment in PSC patients was generally safe, well tolerated and produced sustained improvements in biomarkers linked to…
More Releases for PEG
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-arm…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due…
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition…
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in…
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…
